Style | Citing Format |
---|---|
MLA | Aslany N, et al.. "Effects of Melatonin on Disease Improvement and Serum Levels of Pro-Inflammatory Cytokines in Patients With Non-Atypical Endometrial Hyperplasia." Journal of Immunoassay and Immunochemistry, vol. 45, no. 4, 2024, pp. 382-394. |
APA | Aslany N, Vahedpour Z, Rahimi H, Masjedi M, Motedayyen H (2024). Effects of Melatonin on Disease Improvement and Serum Levels of Pro-Inflammatory Cytokines in Patients With Non-Atypical Endometrial Hyperplasia. Journal of Immunoassay and Immunochemistry, 45(4), 382-394. |
Chicago | Aslany N, Vahedpour Z, Rahimi H, Masjedi M, Motedayyen H. "Effects of Melatonin on Disease Improvement and Serum Levels of Pro-Inflammatory Cytokines in Patients With Non-Atypical Endometrial Hyperplasia." Journal of Immunoassay and Immunochemistry 45, no. 4 (2024): 382-394. |
Harvard | Aslany N et al. (2024) 'Effects of Melatonin on Disease Improvement and Serum Levels of Pro-Inflammatory Cytokines in Patients With Non-Atypical Endometrial Hyperplasia', Journal of Immunoassay and Immunochemistry, 45(4), pp. 382-394. |
Vancouver | Aslany N, Vahedpour Z, Rahimi H, Masjedi M, Motedayyen H. Effects of Melatonin on Disease Improvement and Serum Levels of Pro-Inflammatory Cytokines in Patients With Non-Atypical Endometrial Hyperplasia. Journal of Immunoassay and Immunochemistry. 2024;45(4):382-394. |
BibTex | @article{ author = {Aslany N and Vahedpour Z and Rahimi H and Masjedi M and Motedayyen H}, title = {Effects of Melatonin on Disease Improvement and Serum Levels of Pro-Inflammatory Cytokines in Patients With Non-Atypical Endometrial Hyperplasia}, journal = {Journal of Immunoassay and Immunochemistry}, volume = {45}, number = {4}, pages = {382-394}, year = {2024} } |
RIS | TY - JOUR AU - Aslany N AU - Vahedpour Z AU - Rahimi H AU - Masjedi M AU - Motedayyen H TI - Effects of Melatonin on Disease Improvement and Serum Levels of Pro-Inflammatory Cytokines in Patients With Non-Atypical Endometrial Hyperplasia JO - Journal of Immunoassay and Immunochemistry VL - 45 IS - 4 SP - 382 EP - 394 PY - 2024 ER - |